(Q73316701)
Statements
The advantage of residualizing radiolabels for targeting B-cell lymphomas with a radiolabeled anti-CD22 monoclonal antibody (English)
M J Mattes
L B Shih
S V Govindan
R M Sharkey
G L Ong
H Xuan
scientific article published on 01 May 1997